Breaking News Instant updates and real-time market news.

ESPR

Esperion

$23.67

-5.98 (-20.17%)

, AMGN

Amgen

$168.61

-11.5 (-6.39%)

11:10
03/20/17
03/20
11:10
03/20/17
11:10

Esperion LDL-C lowering endpoint news a clear positive, says JPMorgan

After Esperion (ESPR) announced that the FDA confirmed that the bempedoic acid phase 3 program is adequate to support approval of an LDL-C lowering indication prior to outcomes data, JPMorgan analyst Jessica Fye said some expectation for this type of update "started to come into the stock" after Amgen's (AMGN) release of the FOURIER trial top-line results on last Friday. Still, the news is a clear positive for Esperion as it lifts one of the largest overhangs on the stock over the past 18 months. Fye, who now sees the potential for approval of bempedoic acid in 2020, keeps a Neutral rating on Esperion shares.

ESPR

Esperion

$23.67

-5.98 (-20.17%)

AMGN

Amgen

$168.61

-11.5 (-6.39%)

  • 20

    Mar

  • 20

    Mar

  • 21

    Mar

  • 28

    Mar

  • 19

    Jul

ESPR Esperion
$23.67

-5.98 (-20.17%)

03/20/17
SBSH
03/20/17
NO CHANGE
Target $39
SBSH
Buy
Esperion likely needs to raise cash before FDA approval, says Citi
Following the company's conference call last night, Citi analyst Joel Beatty continues to believe Esperion Therapeutics' bempedoic acid could be approved by FDA based on LDL lowering as a surrogate endpoint. The company will likely need to raise capital before a potential FDA approval, however, Beatty tells investors in a research note. Further, the FDA is unlikely to provide clarity on LDL as a surrogate ahead of a filing in early 2019, the analyst adds. He keeps a Buy rating on Esperion with a $39 price target. The stock in early trading is up 55%, or $13.03, to $36.70.
03/20/17
FBCO
03/20/17
UPGRADE
FBCO
Neutral
Esperion upgraded to Neutral from Underperform at Credit Suisse
03/17/17
NEED
03/17/17
NO CHANGE
Target $25
NEED
Strong Buy
Needham calls Esperion selloff on Amgen data 'counter-intuitive'
Needham analyst Chad Messer believes the selloff in shares of Esperion Therapeutics (ESPR) based on Amgen's (AMGN) Repatha's data is "counter-intuitive." The fact that there was a statistically significant benefit confirms that LDL reductions prevent heart attacks and strokes, Messer tells investors in a research note. Bempedoic acid will likely be priced more in line with other oral cholesterol therapies, which makes the value debate for PCSK9 drugs a positive for Esperion, not a negative, the analyst contends. The analyst keeps a Buy rating on Esperion with a $25 price target.
03/13/17
SBSH
03/13/17
NO CHANGE
Target $39
SBSH
Buy
Esperion selloff Friday a buying opportunity, says Citi
Citi analyst Joel Beatty views Friday's selloff in shares of Esperion Therapeutics as a buying opportunity. Beatty says Reuters' report that President Trump is expected to nominate Scott Gottlieb to lead the FDA is consistent with his Buy thesis on Esperion. The analyst notes that Gottlieb favors deregulation. Beatty keeps a Buy rating on Esperion with a $39 price target.
AMGN Amgen
$168.61

-11.5 (-6.39%)

03/17/17
PIPR
03/17/17
NO CHANGE
PIPR
Overweight
Amgen weakness a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer recommends using today's weakness in shares of Amgen as a buying opportunity. The analyst believes Amgen can still turn Repatha into a $5B-plus product and he reiterates an Overweight rating on the shares.
03/17/17
JPMS
03/17/17
NO CHANGE
JPMS
Overweight
Amgen data do not justify Medicines selloff, says JPMorgan
JPMorgan analyst Jessica Fye believes today's cholesterol data from Amgen (AMGN) do not justify the downward move in shares of The Medicines Co. (MDCO). The analyst sees a "clear clinical benefit" from Amgen's Repatha, which she thinks support the likelihood of clinical success and value for Medicines' inclisiran. The analyst remains comfortable with her 70% probability of success and $1.6B peak sales forecast for inclisiran. Fye keeps an Overweight rating on Medicines and believes the 18% selloff today is overdone.
03/17/17
OPCO
03/17/17
NO CHANGE
OPCO
Outperform
Amgen oversold on cholesterol data, says Oppenheimer
Oppenheimer analyst Leah Rush Cann says shares of Amgen are oversold after the FOURIER study of Repatha in patients with cardiovascular disease met its key endpoint. The risk reduction grew to 25% after one year on Repatha therapy, which is a "very important result," Cann tells investors in a research note. She believes the current stock price reflects little to no sales of Repatha through 2020. The analyst has an Outperform rating on Amgen, which is trading down 6% to $168.68.

TODAY'S FREE FLY STORIES

CCN

CardConnect

$13.65

-0.25 (-1.80%)

, FDC

First Data

$16.64

-0.03 (-0.18%)

20:43
05/29/17
05/29
20:43
05/29/17
20:43
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

CCN

CardConnect

$13.65

-0.25 (-1.80%)

FDC

First Data

$16.64

-0.03 (-0.18%)

AKZOY

AkzoNobel

$28.37

-0.11 (-0.39%)

PPG

PPG

$107.24

0.33 (0.31%)

GM

General Motors

$33.07

0.47 (1.44%)

DIS

Disney

$108.41

1.14 (1.06%)

VIA

Viacom

VIAB

Viacom

$35.13

0.21 (0.60%)

F

Ford

$10.93

0.07 (0.64%)

IP

International Paper

$52.42

0.26 (0.50%)

CROX

Crocs

$6.59

0.12 (1.85%)

YHOO

Yahoo

$50.67

0.07 (0.14%)

FL

Foot Locker

$59.82

0.16 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 01

    Jun

  • 06

    Jun

  • 08

    Jun

  • 12

    Jun

  • 15

    Jun

  • 27

    Jul

  • 25

    Oct

AMGP

Antero Midstream GP

$21.97

-0.09 (-0.41%)

20:34
05/29/17
05/29
20:34
05/29/17
20:34
Initiation
Antero Midstream GP initiated  »

Antero Midstream GP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AM

Antero Midstream

$34.28

-0.06 (-0.17%)

20:32
05/29/17
05/29
20:32
05/29/17
20:32
Initiation
Antero Midstream initiated  »

Antero Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLP

Archrock Partners LP

20:30
05/29/17
05/29
20:30
05/29/17
20:30
Downgrade
Archrock Partners LP rating change  »

Archrock Partners LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGP

Antero Midstream

$21.97

-0.09 (-0.41%)

20:28
05/29/17
05/29
20:28
05/29/17
20:28
Initiation
Antero Midstream initiated  »

Antero Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$61.00

0.29 (0.48%)

20:27
05/29/17
05/29
20:27
05/29/17
20:27
Initiation
Occidental Petroleum initiated  »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRO

Frontline

$5.63

-0.39 (-6.48%)

, AMWD

American Woodmark

$88.90

1.3 (1.48%)

20:25
05/29/17
05/29
20:25
05/29/17
20:25
Earnings
Notable companies reporting before Tuesday's open »

Notable companies…

FRO

Frontline

$5.63

-0.39 (-6.48%)

AMWD

American Woodmark

$88.90

1.3 (1.48%)

SFL

Ship Finance

$13.05

-0.25 (-1.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 30

    May

WDC

Western Digital

$90.01

0.74 (0.83%)

, TOSBF

Toshiba, also use TOSYY

$2.30

0.0023 (0.10%)

20:04
05/29/17
05/29
20:04
05/29/17
20:04
Periodicals
INCJ considers joint bid with Western Digital for Toshiba chips, Nikkei says »

State-backed Innovation…

WDC

Western Digital

$90.01

0.74 (0.83%)

TOSBF

Toshiba, also use TOSYY

$2.30

0.0023 (0.10%)

TOSYY

Toshiba, also use TOSBF

$13.80

-0.1 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$971.47

1.93 (0.20%)

, GOOGL

Alphabet Class A

$993.27

1.41 (0.14%)

20:01
05/29/17
05/29
20:01
05/29/17
20:01
Periodicals
Google, Sharp partner on VR displays, Nikkei says »

Google (GOOG) and…

GOOG

Alphabet

$971.47

1.93 (0.20%)

GOOGL

Alphabet Class A

$993.27

1.41 (0.14%)

HNHPF

Hon Hai Precision

SHCAY

Sharp

$3.80

0.1 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

  • 28

    Jun

  • 19

    Jul

MU

Micron

$29.76

0.33 (1.12%)

19:58
05/29/17
05/29
19:58
05/29/17
19:58
Periodicals
Micron to invest $2B in Japan memory chip facility, Nikkei says »

Micron plans to invest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 05

    Jun

  • 06

    Jun

  • 06

    Jun

  • 07

    Jun

  • 09

    Jun

  • 15

    Jun

LNEGY

Linde

$19.28

-0.09 (-0.46%)

19:56
05/29/17
05/29
19:56
05/29/17
19:56
Periodicals
Linde to receive 'major' order from Russian company, Reuters says »

Linde is set to receive a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDC

First Data

$16.64

-0.03 (-0.18%)

, CCN

CardConnect

$13.65

-0.25 (-1.80%)

19:38
05/29/17
05/29
19:38
05/29/17
19:38
Hot Stocks
First Data to acquire CardConnect for $15.00 per share »

First Data (FDC) and…

FDC

First Data

$16.64

-0.03 (-0.18%)

CCN

CardConnect

$13.65

-0.25 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

SSNLF

Samsung

$2,000.00

200 (11.11%)

, LYV

Live Nation

$34.25

0.05 (0.15%)

19:33
05/29/17
05/29
19:33
05/29/17
19:33
Hot Stocks
Samsung announces 'VR Live Pass,' new virtual reality partnerships »

Samsung (SSNLF) announced…

SSNLF

Samsung

$2,000.00

200 (11.11%)

LYV

Live Nation

$34.25

0.05 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

FISV

Fiserv

$124.09

-0.43 (-0.35%)

19:31
05/29/17
05/29
19:31
05/29/17
19:31
Hot Stocks
Fiserv says selected by Bank of Sydney »

Fiserv announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$37.55

1.6 (4.45%)

19:29
05/29/17
05/29
19:29
05/29/17
19:29
Periodicals
Nintendo orders production ramp for 'Switch' console, FT reports »

Nintendo has ordered a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$325.14

8.31 (2.62%)

, CSIQ

Canadian Solar

$13.24

-0.48 (-3.50%)

19:16
05/29/17
05/29
19:16
05/29/17
19:16
Hot Stocks
WTO says U.S. launches investigation into solar cell imports »

The World Trade…

TSLA

Tesla

$325.14

8.31 (2.62%)

CSIQ

Canadian Solar

$13.24

-0.48 (-3.50%)

FSLR

First Solar

$36.84

-1.1 (-2.90%)

JASO

JA Solar

$6.91

-0.28 (-3.89%)

SPWR

SunPower

$7.95

-0.28 (-3.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 06

    Jun

  • 20

    Jun

  • 29

    Jun

  • 02

    Oct

LRLCY

L'Oreal

$42.24

-0.165 (-0.39%)

18:47
05/29/17
05/29
18:47
05/29/17
18:47
Periodicals
Renhe Pharmacy mulls joining auction for The Body Shop, Sky News says »

China's Renhe…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$153.61

-0.26 (-0.17%)

, QCOM

Qualcomm

$57.52

-0.93 (-1.59%)

18:43
05/29/17
05/29
18:43
05/29/17
18:43
Periodicals
Apple hires former Qualcomm VP to head SoC efforts, AppleInsider says »

Apple (AAPL) has hired…

AAPL

Apple

$153.61

-0.26 (-0.17%)

QCOM

Qualcomm

$57.52

-0.93 (-1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

GS

Goldman Sachs

$223.53

1.06 (0.48%)

18:40
05/29/17
05/29
18:40
05/29/17
18:40
Periodicals
Goldman Sachs bought $2.8B in Venezuelan bonds, WSJ says »

Goldman Sachs purchased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 18

    Jul

  • 17

    Oct

ICAGY

IAG

$15.65

-0.305 (-1.91%)

18:36
05/29/17
05/29
18:36
05/29/17
18:36
Hot Stocks
British Airways suffers 'major' IT failure »

IAG's British…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNI

Canadian National

$77.01

-0.47 (-0.61%)

18:20
05/29/17
05/29
18:20
05/29/17
18:20
Hot Stocks
Canadian National reaches tentative labor with train conductors, yard employees »

CN announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$107.24

0.33 (0.31%)

, AKZOY

AkzoNobel

$28.37

-0.11 (-0.39%)

16:29
05/29/17
05/29
16:29
05/29/17
16:29
Hot Stocks
PPG says remains willing to engage with AkzoNobel »

PPG (PPG) issued the…

PPG

PPG

$107.24

0.33 (0.31%)

AKZOY

AkzoNobel

$28.37

-0.11 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$107.24

0.33 (0.31%)

, AKZOY

AkzoNobel

$28.37

-0.11 (-0.39%)

16:27
05/29/17
05/29
16:27
05/29/17
16:27
Periodicals
Court rejects Elliott challenge against AkzoNobel, Bloomberg says »

The Dutch Commercial…

PPG

PPG

$107.24

0.33 (0.31%)

AKZOY

AkzoNobel

$28.37

-0.11 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$108.41

1.14 (1.06%)

, VIA

Viacom

16:21
05/29/17
05/29
16:21
05/29/17
16:21
Hot Stocks
Box Office Battle: 'Pirates' wins holiday weekend as 'Baywatch' stumbles »

Disney's (DIS)…

DIS

Disney

$108.41

1.14 (1.06%)

VIA

Viacom

VIAB

Viacom

$35.13

0.21 (0.60%)

FOX

21st Century Fox

$26.95

-0.28 (-1.03%)

FOXA

21st Century Fox

$27.03

-0.3 (-1.10%)

TWX

Time Warner

$99.07

0.1025 (0.10%)

CMCSA

Comcast

$40.91

0.57 (1.41%)

CMCSK

Comcast

LGF.A

Lionsgate

$27.76

2.21 (8.65%)

LGF.B

Lionsgate

$25.56

2.11 (9.00%)

SNE

Sony

$36.68

0.51 (1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jun

  • 12

    Jun

  • 15

    Jun

  • 15

    Jun

  • 27

    Jun

DGAS

Delta Natural Gas

15:56
05/29/17
05/29
15:56
05/29/17
15:56
Conference/Events
Delta Natural Gas to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.